MEGAN KNIES: Open Payments
NPI 1902438260 · LAKEWOOD RANCH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,746 in 48 payments from 12 companies in 2025. Trend: 2023 $2,414 · 2024 $1,374 · 2025 $1,746
Food & beverage: $1,746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $457 |
| UCB, Inc. | 6 | $291 |
| Lilly USA, LLC | 6 | $276 |
| Regeneron Healthcare Solutions, Inc. | 3 | $249 |
| PFIZER INC. | 4 | $105 |
| Janssen Biotech, Inc. | 5 | $95 |
| LEO Pharma Inc. | 3 | $82 |
| GENZYME CORPORATION | 2 | $62 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TALTZ, RINVOQ, EBGLYSS, CIBINQO, TREMFYA.
Industry payments across FL — which companies pay providers there.
